NASDAQ$ENSG

The Ensign Group Inc. · Q1 2024 earnings

Q1 2024 earnings · · Investor relations

Briefing

Ensign Group's Q1 2024 financial results were reported, showcasing increased earnings and revenue growth.

Ensign Group reported a strong first quarter in 2024, with significant increases in GAAP diluted earnings per share, adjusted earnings per share, GAAP net income, and adjusted net income. The company also saw growth in same-facility occupancy and skilled revenue, as well as managed care census.

  • GAAP diluted earnings per share increased by 13.3% year-over-year to $1.19.
  • Adjusted diluted earnings per share increased by 15.0% year-over-year to $1.30.
  • Consolidated GAAP and adjusted revenue increased by 13.9% year-over-year to $1.01 billion.
  • Same facilities occupancy reached 81.0%, a 2.7% increase over the prior year quarter.

Headline financials

Total Revenue

$1.01B

Previous: $887M+13.9%
EPS

$1.19

Previous: $1.13+5.3%
Skilled Nursing Revenue - Medicare

25.0%

No prior period
Skilled Nursing Revenue - Medicaid

48.4%

No prior period
Skilled Nursing Revenue - Managed Care

17.7%

No prior period
Skilled Nursing Revenue - Private/Other

8.9%

No prior period
Capital Expenditures

-$29.4M

No prior period
Free Cash Flow

$68.8M

Previous: $59.9M+15.0%
Net Income

$68.8M

Previous: $59.9M+15.0%
Operating Income

$82.2M

Previous: $74.9M+9.8%
Gross Profit

$211M

Previous: $191M+10.7%
Cash & Equivalents

$512M

Previous: $327M+56.5%
Total Assets

$4.31B

Previous: $3.86B+11.6%
Stock-Based Comp

$8.24M

Previous: $6.57M+25.3%

Revenue & EPS history

Ensign Group · Revenue · Quarterly

$1.01B

Q1 2024+13.9%vs Q1 2023
Beat estimate in 9 of 15 quarters(60%)
ActualEstimate

Revenue by segment

Ensign Group · $924M total across 2 segments · Q3 2023

  • Skilled Services
    $903M+22.1%
  • Standard Bearer
    $21M+12.3%

Forward guidance

The company is affirming its annual 2024 earnings guidance of $5.29 to $5.47 per diluted share and annual revenue guidance of $4.13 billion to $4.17 billion.

Tailwinds

  • Annual 2024 earnings guidance of $5.29 to $5.47 per diluted share.
  • Annual revenue guidance of $4.13 billion to $4.17 billion.
  • Midpoint of earnings guidance represents a 13% increase over 2023 results.
  • Earnings guidance is 30% higher than 2022 results.
  • Company is well-positioned to meet or exceed guidance in 2024.

Headwinds

  • Guidance assumes normalized health insurance costs.
  • Guidance assumes management's current expectations regarding reimbursement rates.
  • Guidance excludes certain one-time charges.
  • One-time charges include expenses related to litigation matters arising outside of the ordinary course of business.
  • One-time charges include impairment of long-lived assets, acquisition-related costs, amortization costs related to intangible assets acquired and share-based compensation.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2024

Historical avgQ1 2024

+1.7%

Avg return

Earnings day

+2.4%

Avg return

5 days after

+4.9%

Avg return

30 days after

55%

36 / 66 earnings

Positive

+21.1%

Q2 2020

Best reaction

-14.9%

Q4 2016

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-1.2%-5.8%-10.2%
Q4 2025+13.8%+17.8%+19.7%
Q3 2025-0.1%-2.1%-3.2%
Q2 2025+0.1%+1.8%+1.2%
Q1 2025+0.7%+2.9%+14.9%
Q4 2024-8.7%-13.3%-12.4%
Q3 2024+1.9%+4.6%-2.4%
Q2 2024+4.5%+6.5%+8.4%
Q1 2024-1.5%-2.0%+2.4%
Q4 2023+6.7%+3.9%+7.7%
Q3 2023-1.4%-1.4%+13.3%
Q2 2023+1.4%+3.2%+7.0%
Q1 2023-5.7%-4.6%-13.1%
Q4 2022-1.7%-4.4%-2.7%
Q3 2022-1.9%+1.8%+6.7%
Q2 2022+9.5%+6.5%+7.0%
Q1 2022-1.4%-3.8%+1.1%
Q4 2021+7.9%+6.0%+15.9%
Q3 2021+8.3%+11.3%+10.6%
Q2 2021-2.5%-1.3%-3.8%
Q1 2021-3.3%-2.5%-6.3%
Q4 2020+0.4%-2.1%-6.3%
Q3 2020+2.8%+4.8%+23.2%
Q2 2020+21.1%+21.5%+20.9%
Q1 2020+2.6%+2.6%+22.6%
Q4 2019+11.6%+13.9%-2.5%
Q3 2019+1.1%+1.9%+3.9%
Q2 2019-10.3%-15.7%-17.2%
Q1 2019-1.0%+5.0%+4.2%
Q4 2018+11.3%+10.0%+10.2%
Q3 2018+11.2%+20.5%+21.1%
Q2 2018-2.7%-0.1%+8.4%
Q1 2018+12.4%+17.8%+30.7%
Q4 2017+7.5%+8.7%+20.1%
Q3 2017-0.8%-0.2%-2.9%
Q2 2017-7.4%-7.3%-4.4%
Q1 2017+10.4%+9.5%+2.4%
Q4 2016-14.9%-15.5%-8.9%
Q3 2016+3.4%+5.3%+20.7%
Q2 2016-12.2%-8.9%-12.6%
Q1 2016+1.1%
Q4 2015-5.6%
Q3 2015+13.0%
Q2 2015-0.8%
Q1 2015+5.7%
Q4 2014-6.0%
Q3 2014+5.3%
Q2 2014-1.9%
Q1 2014-2.0%
Q4 2013-1.0%
Q3 2013+3.5%
Q2 2013-3.9%
Q1 2013-5.3%
Q4 2012+3.1%
Q3 2012-5.1%
Q2 2012+2.6%
Q1 2011-0.7%
Q1 2012-0.7%
Q4 2011+7.7%
Q4 2009+7.7%
Q3 2011+12.7%
Q3 2010+12.7%
Q4 2010+1.2%
Q2 2010+1.2%
Q2 2011+1.2%
Q1 2010-3.4%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro